Dr Emma Tallantyre

Dr Emma Tallantyre

Clinical Senior Lecturer, Division of Psychological Medicine and Clinical Neuroscience

School of Medicine

Email:
tallantyreec@cardiff.ac.uk
Telephone:
+44 (0)29 2074 5403
Location:
Room 91E, 4th Floor B-C Link Corridor, University Hospital Wales

I graduated from medical school at the University of Nottingham in 2002. I undertook my postgraduate medical and neurological training in Nottingham, Derby, Australia and South Wales. As an MRC research fellow, I completed a PhD investigating imaging (Sir Peter Mansfield MR centre) and neuropathology (Nottingham University) of multiple sclerosis (MS).

I have been involved in the clinical care of people with MS since 2006. I completed my clinical training in 2015 and became a Clinical Senior Lecturer in Neurology in 2018. I hold an honorary contract to work within the Helen Durham Neuroinflammatory Unit of the University Hospital of Wales. As part of this role I run weekly MS and general neurology clinics and contribute to service development.

My current research interests centre on the outcomes of neuroinflammatory disease. I am involved in clinical trials that investigate the optimum treatment approaches in multiple sclerosis. I have an interest in combining real world clinical data with associated biological and imaging data to strengthen predictions of outcome and improve trial design. I am also interested in the involvement of patients and the public in the development of clinical research studies.

Academic and clinical positions

Consultant Neurologist

University Hospital of Wales

March 2017 – present

Clinical Senior Lecturer

Cardiff University

March 2016 – Feb 2017

Post-CCT Research Fellow

Neurology SpR

University Hospital of Wales

Wales Deanery

July 2015 –Feb 2016

Aug 2012 – July 2015

Neurology SpR

East Midlands Deanery

August 2009 – August 2012

Speaking engagements

  • What is the next drug for MS? Invited talk at Association of British Neurologists Annual Meeting, Birmingham, May 2018.
  • Multiple Sclerosis Academy, MS Masterclass, Sheffield, 2017
  • MS Society Cymru 60th anniversary event, Cardiff, 2017.
  • How common is truly benign MS? EC Tallantyre, P Major, WA Davies, M Atherton, K Harding, T Pickersgill, M Winter, N Robertson. Association of British Neurologists Annual Meeting, Liverpool, May 2017.
  • Secondary Antibody Deficiency and infection following B-cell depletion for CNS neuroinflammation. EC Tallantyre, D Whittam, S Jolles, N Robertson, A Jacob. Association of British Neurologists Annual Meeting, Liverpool, May 2017.
  • Biogen MRI in MS meeting, co-organiser and speaker, Cardiff, 2017
  • National MS Debating society, Edinburgh, 2017.
  • Grand Challenge workshop: designing a next generation clinical trial in MS, London, 2016.
  • Becoming a neurology trainee: Mentoring, top tips for research & audit work-life balance. Foundation Doctors Session, Association of British Neurologists Annual Meeting, Harrogate, May 2015.
  • MS Trust annual conference, Windsor, 2015.
  • The Shape of Training. Association of British Neurologists Annual Meeting, Cardiff, May 2014.
  • Differential diagnosis in a Relapse Clinic. South Wales MS Day, May 2013.

2018

2017

2016

2015

2013

I contribute to the C21 Medical Undergraduate neurology teaching. I am clinical tutor to 4th year students rotating through Neurology placements and have also been undergraduate tutor to a group of 1st – 2nd year students since they entered the medical course.

I run a regular programme of 3rd and 4th year SSC projects as well as BSc intercalated projects for the undergraduate medical course. We receive consistently good feedback from our students and enjoy the interaction they bring to the department.

I have experience in using high field structural imaging to visualise white matter and grey matter pathology in the brains of people with MS. During my PhD I correlated in vivo MR imaging findings with the neurodegenerative pathology seen in the post mortem brains and spinal cords of those with longstanding MS.

My current research interests centre on the outcomes of neuroinflammatory disease. I am involved in clinical trials that investigate the optimum treatment approaches in multiple sclerosis. I contribute to a long running epidemiological project, prospectively collecting clinical data from a population-based cohort of people with neuroinflammatory diseases including MS. I have an interest in combining this real world clinical data with associated biological and imaging data to strengthen predictions of outcome and improve trial design. I am also interested in the involvement of patients and the public in the development of clinical research studies.

Grants and Awards

  • Patient-Centred Outcome Research Institute (PCORI; co-applicant) 2017 - Determining the Effectiveness of Early Intensive versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis (DELIVER-MS) -£7.5m.
  • MS Society 2017 (co-applicant) - Life-style, Exercise and Activity Package for People living with Progressive Multiple Sclerosis (LEAP-MS) - £293,000.
  • Health and Care Research Wales - Clinical Research Award 2016 - £67,927
  • Wellcome Trust Institutional Strategic Support Fund Award (co-applicant) 2015 - £34,000
  • Trainees Transforming Training 2015 - £5,000
  • Biogen Idec MS Global Registry Fellowship 2014 - £62,000
  • MRC Clinical Training Fellowship, 2007 - £100,000
  • Peele Medical Trust, Research grant, 2006 - £5,000